Your search returned 14 results.

Results
	1.	Effect of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, on measurement of serum 1,5-anhydroglucitol. [electronic resource] by Balis, Dainius A Tong, Cindy Meininger, Gary Producer: 20150122 In: Journal of diabetes vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Canagliflozin: Efficacy and Safety in Combination with Metformin Alone or with Other Antihyperglycemic Agents in Type 2 Diabetes. [electronic resource] by Qiu, Rong Balis, Dainius Capuano, George Xie, John Meininger, Gary Publication details: Diabetes therapy : research, treatment and education of diabetes and related disorders Dec 2016 In: Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Influence of continuous venovenous hemofiltration and continuous venovenous hemodiafiltration on the disposition of doripenem. [electronic resource] by Cirillo, Iolanda Vaccaro, Nicole Balis, Dainius Redman, Rebecca Matzke, Gary R Producer: 20110601 In: Antimicrobial agents and chemotherapy vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome. [electronic resource] by Davies, Michael J Merton, Katherine W Vijapurkar, Ujjwala Balis, Dainius A Desai, Mehul Publication details: Diabetes, metabolic syndrome and obesity : targets and therapy 2017 In: Diabetes, metabolic syndrome and obesity : targets and therapy vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Longer-term safety and tolerability of canagliflozin in patients with type 2 diabetes: a pooled analysis. [electronic resource] by Qiu, Rong Balis, Dainius Xie, John Davies, Michael J Desai, Mehul Meininger, Gary Producer: 20170928 In: Current medical research and opinion vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Renal safety of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus. [electronic resource] by Desai, Mehul Yavin, Yshai Balis, Dainius Sun, Don Xie, John Canovatchel, William Rosenthal, Norm Producer: 20180403 In: Diabetes, obesity & metabolism vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects. [electronic resource] by Heerspink, Hiddo J L Desai, Mehul Jardine, Meg Balis, Dainius Meininger, Gary Perkovic, Vlado Producer: 20170602 In: Journal of the American Society of Nephrology : JASN vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Assessment of musculoskeletal toxicity 5 years after therapy with levofloxacin. [electronic resource] by Bradley, John S Kauffman, Ralph E Balis, Dainius A Duffy, Ciaran M Gerbino, Peter G Maldonado, Samuel D Noel, Gary J Producer: 20140904 In: Pediatrics vol. 134 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial. [electronic resource] by Cefalu, William T Leiter, Lawrence A Yoon, Kun-Ho Arias, Pablo Niskanen, Leo Xie, John Balis, Dainius A Canovatchel, William Meininger, Gary Producer: 20130926 In: Lancet (London, England) vol. 382 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Canagliflozin provides durable glycemic improvements and body weight reduction over 104 weeks versus glimepiride in patients with type 2 diabetes on metformin: a randomized, double-blind, phase 3 study. [electronic resource] by Leiter, Lawrence A Yoon, Kun-Ho Arias, Pablo Langslet, Gisle Xie, John Balis, Dainius A Millington, Dawn Vercruysse, Frank Canovatchel, William Meininger, Gary Producer: 20150827 In: Diabetes care vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation. [electronic resource] by Nicholson, Susan C Welte, Tobias File, Thomas M Strauss, Richard S Michiels, Bart Kaul, Pratibha Balis, Dainius Arbit, Deborah Amsler, Karen Noel, Gary J Producer: 20120615 In: International journal of antimicrobial agents vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media. [electronic resource] by Noel, Gary J Blumer, Jeffrey L Pichichero, Michael E Hedrick, James A Schwartz, Richard H Balis, Dainius A Melkote, Rama Bagchi, Partha Arguedas, Adriano Producer: 20080703 In: The Pediatric infectious disease journal vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders. [electronic resource] by Noel, Gary J Bradley, John S Kauffman, Ralph E Duffy, Ciaran M Gerbino, Peter G Arguedas, Adriano Bagchi, Partha Balis, Dainius A Blumer, Jeffrey L Producer: 20071127 In: The Pediatric infectious disease journal vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Canagliflozin: a sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes mellitus. [electronic resource] by Rosenthal, Norm Meininger, Gary Ways, Kirk Polidori, David Desai, Mehul Qiu, Rong Alba, Maria Vercruysse, Frank Balis, Dainius Shaw, Wayne Edwards, Robert Bull, Scott Di Prospero, Nicholas Sha, Sue Rothenberg, Paul Canovatchel, William Demarest, Keith Producer: 20160523 In: Annals of the New York Academy of Sciences vol. 1358 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)